Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance

Publisher: Bentham Science Publishers

E-ISSN: 2212-3962|7|1|33-41

ISSN: 1574-8901

Source: Recent Patents on Cardiovascular Drug Discovery, Vol.7, Iss.1, 2012-04, pp. : 33-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content